ALMS

Alumis Inc. - Common Stock (ALMS)

About Alumis Inc. - Common Stock (ALMS)

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Details

Daily high

$4.49

Daily low

$4.16

Price at open

$4.29

52 Week High

$16.00

52 Week Low

$3.18

Market cap

232.9M

Dividend yield

0.00%

Volume

181,491

Avg. volume

627,911

P/E ratio

-.78

Alumis Inc. - Common Stock News